Khalid Shah

发表

In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.

D. Auer, A. Napolitano, K. Fone, 2014, Schizophrenia bulletin.

Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS

Jun R Huh, Jun R. Huh, Khalid Shah, 2022, EBioMedicine.

Tartary buckwheat extract alleviates alcohol-induced acute and chronic liver injuries through the inhibition of oxidative stress and mitochondrial cell death pathway.

Mohammed Akbar, Y. Tu, B. Song, 2020, American journal of translational research.

Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy

K. Shah, M. Matin, Yizheng Yao, 2020, Scientific Reports.

Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy

Y. Aras, Gökçen Ünverengil, E. Tüzün, 2023, bioRxiv.

The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.

Khalid Shah, Longsha Liu, 2022, JAMA oncology.

Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas

H. Wakimoto, G. Boland, Nobuhiko Kanaya, 2023, Science Translational Medicine.

Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer

Jeffrey J. Gray, J. J. Gray, Jing Zhou, 2023, Stem cells translational medicine.

Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding

Yongxin Zhao, Jenna Aronson, D. Bhere, 2024, Science Translational Medicine.

Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment.

Filippo Rossignoli, Khalid Shah, Jan Gettemans, 2024, Cytotherapy.

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Filippo Rossignoli, Khalid Shah, Longsha Liu, 2024, Frontiers in immunology.

Developing and characterizing a two-layered safety switch for cell therapies

Filippo Rossignoli, Khalid Shah, Danielle Hoffman, 2023, Cancer biology & therapy.